Rhabdomyolysis in Patients with Hemoblastoses during Intensive Chemotherapy

Rhabdomyolysis in Patients with Hemoblastoses during Intensive Chemotherapy

Objective: to define the clinical significance of rhabdomyolysis in patients with hemoblastoses during intensive chemotherapy. Subjects and methods. The study included 63 hematoblastosis patients aged 20 to 71 years (median 42 years) who received intensive chemotherapy that was referred as to grade...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V Lyanguzov, L. V. Kolotilov, T. P. Zagoskina
Format:	Article
Language:	English
Published:	Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2009-08-01
Series:	Общая реаниматология
Online Access:	https://www.reanimatology.com/rmt/article/view/556
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Specifics of the telemedicine in patients with paraproteinemic hemoblastoses
by: M. V. Soloveva, et al.
Published: (2023-05-01)

ONCOIMMUNOLOGY, HEMOBLASTOSES
by: Editorial article
Published: (2014-07-01)

ONCOIMMUNOLOGY, HEMOBLASTOSES
by: Editorial article
Published: (2014-07-01)

ONCOIMMUNOLOGY, HEMOBLASTOSES
by: Editorial article
Published: (2014-07-01)

ONCOIMMUNOLOGY, HEMOBLASTOSES
by: Editorial article
Published: (2014-07-01)

Prospects for Use of Heptral in Hemoblastoses
by: V. B. Larionova, et al.
Published: (2008-08-01)

Influence of nutritional support on tolerability and results of treatment in patients with newly diagnosed hemoblastoses received program chemotherapy
by: N. P. Shen’, et al.
Published: (2022-11-01)

Disputable questions of statins antitumor effects in hemoblastoses
by: R. N. Mustafin
Published: (2022-07-01)

Molecular Genetic Typing of Enterobacteriaceae Producing an Extended Spectrum Beta-Lactamase in Patients with Hemoblastoses
by: A. G. Korobova, et al.
Published: (2020-05-01)

Predictive model for assessing the prognosis of rhabdomyolysis patients in the intensive care unit
by: Yaxin Xiong, et al.
Published: (2025-01-01)

Monoclonal immunoglobulin as a prognostic factor for the severity of bone damage in paraproteinemic hemoblastoses and Waldenström’s macroglobulinemia
by: O. N. Pisarevskaya, et al.
Published: (2024-01-01)

Rhabdomyolysis in intensive care unit—distinctive clinical indicators and prognosis
by: Zhen Wang, et al.
Published: (2025-02-01)

Acute rhabdomyolysis
by: Pascale de Lonlay, et al.
Published: (2015-05-01)

Rhabdomyolysis Occurred Again after Changing Chemotherapy Regimens in Ovarian Cancer: A Case Report
by: Shaocong Cao, et al.
Published: (2024-11-01)

Rhabdomyolysis Complicating Unrecognized Hypophosphatemia in an Alcoholic Patient
by: Deepali Kumar, et al.
Published: (1999-01-01)

Exercise induced rhabdomyolysis
by: Ružič Maja, et al.
Published: (2009-01-01)

SPECIFIC FEATURES OF PSYCHOLOGICAL CARE FOR PATIENTS WITH PULMONARY TUBERCULOSIS DURING INTENSIVE CHEMOTHERAPY (IN THE HOSPITAL SETTING)
by: V. V. Streltsov, et al.
Published: (2014-02-01)

Clinical characteristics of spinning-induced rhabdomyolysis and other causes of rhabdomyolysis: a comparative study
by: Kashyap Shroff, et al.
Published: (2022-10-01)

Rhabdomyolysis associated with the use of tirzepatide
by: Kunal Sonavane, et al.
Published: (2025-04-01)

Nelarabine Associated Myotoxicity and Rhabdomyolysis
by: Mahnur Haider, et al.
Published: (2015-01-01)

Causes of rhabdomyolysis in acute poisonings
by: Janković Snežana R., et al.
Published: (2013-01-01)

Rhabdomyolysis due to Multiple Wasp Stings
by: K. Ito, et al.
Published: (2012-01-01)

A Case of Relugolix-Associated Rhabdomyolysis
by: Benjamin Tanenbaum, et al.
Published: (2023-10-01)

A Metabolism Perspective on Pediatric Rhabdomyolysis
by: Havva Yazıcı, et al.
Published: (2021-12-01)

Automated Fluid Management for Treatment of Rhabdomyolysis
by: Christian M. Beilstein, et al.
Published: (2016-01-01)

Rhabdomyolysis and Cardiomyopathy in a 20-Year-Old Patient with CPT II Deficiency
by: M. Vavlukis, et al.
Published: (2014-01-01)

Rhabdomyolysis in Patients with Drug or Chemical Poisoning: Clinical Investigation and Implications
by: Fateme Eghbali, et al.
Published: (2025-07-01)

Choice of Treatment Used in a Patient With Antipsychotic-Induced Rhabdomyolysis
by: Mizanoor Rahman, et al.
Published: (2025-06-01)

One case of rhabdomyolysis resulting from fenofibrate in hemodialysis patients
by: CHENG Li, et al.
Published: (2019-01-01)

Severe Rhabdomyolysis After COVID-19 Vaccine
by: Céline Imhof, et al.
Published: (2022-07-01)

Fipronil poisoning presenting as seizures and rhabdomyolysis - an unusual presentation
by: B. R. C. M. Basnayake, et al.
Published: (2025-03-01)

Use of Selective Hemosorption and Hemodiafiltration in a Patient with Toxic Rhabdomyolysis Complicated by Acute Kidney Injury
by: S. V. Masolitin, et al.
Published: (2022-12-01)

Sitagliptin and Simvastatin Interaction Causing Rhabdomyolysis and AKI
by: Chinmay Patel, et al.
Published: (2019-01-01)

Drug-Induced Rhabdomyolysis with Elevated Cardiac Troponin T
by: Gro Egholm, et al.
Published: (2015-01-01)

Case Report: Rhabdomyolysis following initiation of tirzepatide
by: Jonas Michael Bodanowitz, et al.
Published: (2025-08-01)

Statin-Induced Rhabdomyolysis: A Rare Case
by: Vijaya Pamidimukkala
Published: (2024-01-01)

Rhabdomyolysis in Children: A State-of-the-Art Review
by: Manson Chon In Kuok, et al.
Published: (2025-04-01)

Abrocitinib-related rhabdomyolysis: A case report
by: Ya-Wen Hsiao, et al.
Published: (2024-11-01)

RYR1 Mutations, Exertional Myalgia and Rhabdomyolysis
by: J Gordon Millichap
Published: (2013-07-01)

Legionnaires’ Disease Complicated with Rhabdomyolysis and Acute Kidney Injury in an AIDS Patient
by: Karan Seegobin, et al.
Published: (2017-01-01)